Validating the disruption of proliferating cell nuclear antigen interactions in the development of targeted cancer therapeutics

Expression of a novel peptide derived from PCNA damages DNA and reverses cisplatin resistance

(2014) Robert G. Lingeman et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

A PCNA-Derived Cell Permeable Peptide Selectively Inhibits Neuroblastoma Cell Growth

(2014) Long Gu et al.   PLoS One

Phosphorylation of the p68 Subunit of Pol δ Acts as a Molecular Switch To Regulate Its Interaction with PCNA

(2011) Amal A. Rahmeh et al.   BIOCHEMISTRY

P50, the Small Subunit of DNA Polymerase Delta, Is Required for Mediation of the Interaction of Polymerase Delta Subassemblies with PCNA

(2011) Yujue Wang et al.   PLoS One

Proliferating cell nuclear antigen (PCNA): a key factor in DNA replication and cell cycle regulation

(2010) Wojciech Strzalka et al.   ANNALS OF BOTANY

Elevated expression of cancer-associated proliferating cell nuclear antigen in high-grade prostatic intraepithelial neoplasia and prostate cancer

(2010) Xiaoyan Wang et al.   PROSTATE

PCNA Is Required for Initiation of Recombination-Associated DNA Synthesis by DNA Polymerase δ

(2009) Xuan Li et al.   MOLECULAR CELL

Polymerase Dynamics at the Eukaryotic DNA Replication Fork

(2008) Peter M. J. Burgers   JOURNAL OF BIOLOGICAL CHEMISTRY

Human hepatocellular carcinoma expresses specific PCNA isoforms: an in vivo and in vitro evaluation

(2008) Annamaria Venturi et al.   LABORATORY INVESTIGATION